Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP331028.RAseJI4BbMCaYnOCMhA_U5qcwCuMkfDJXopXg4I0QscZk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP331028.RAseJI4BbMCaYnOCMhA_U5qcwCuMkfDJXopXg4I0QscZk130_assertion type Assertion NP331028.RAseJI4BbMCaYnOCMhA_U5qcwCuMkfDJXopXg4I0QscZk130_head.
- NP331028.RAseJI4BbMCaYnOCMhA_U5qcwCuMkfDJXopXg4I0QscZk130_assertion description "[To investigate the frequency of MHC Class II antigen expression in PTC and to identify the effects of MHC Class II antigen expression on clinical outcomes in PTC patients, the expression of HLA-DR/-DQ antigen was analyzed in surgical specimens from 77 PTCs and 44 benign nodules (23 nodular hyperplasias, 21 follicular adenomas).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331028.RAseJI4BbMCaYnOCMhA_U5qcwCuMkfDJXopXg4I0QscZk130_provenance.
- NP331028.RAseJI4BbMCaYnOCMhA_U5qcwCuMkfDJXopXg4I0QscZk130_assertion evidence source_evidence_literature NP331028.RAseJI4BbMCaYnOCMhA_U5qcwCuMkfDJXopXg4I0QscZk130_provenance.
- NP331028.RAseJI4BbMCaYnOCMhA_U5qcwCuMkfDJXopXg4I0QscZk130_assertion SIO_000772 17957790 NP331028.RAseJI4BbMCaYnOCMhA_U5qcwCuMkfDJXopXg4I0QscZk130_provenance.
- NP331028.RAseJI4BbMCaYnOCMhA_U5qcwCuMkfDJXopXg4I0QscZk130_assertion wasDerivedFrom befree-20140225 NP331028.RAseJI4BbMCaYnOCMhA_U5qcwCuMkfDJXopXg4I0QscZk130_provenance.
- NP331028.RAseJI4BbMCaYnOCMhA_U5qcwCuMkfDJXopXg4I0QscZk130_assertion wasGeneratedBy ECO_0000203 NP331028.RAseJI4BbMCaYnOCMhA_U5qcwCuMkfDJXopXg4I0QscZk130_provenance.